Ontrak (OTRK) Competitors $1.45 +0.05 (+3.32%) Closing price 03:51 PM EasternExtended Trading$1.44 -0.01 (-0.81%) As of 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OTRK vs. ENZ, OPGN, CCM, MRAI, BRTX, KDLY, MGRX, SSY, NIVF, and ATIPShould you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include Enzo Biochem (ENZ), OpGen (OPGN), Concord Medical Services (CCM), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), SunLink Health Systems (SSY), NewGenIvf Group (NIVF), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. Ontrak vs. Enzo Biochem OpGen Concord Medical Services Marpai BioRestorative Therapies Kindly MD Mangoceuticals SunLink Health Systems NewGenIvf Group ATI Physical Therapy Enzo Biochem (NYSE:ENZ) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, community ranking, institutional ownership, valuation, media sentiment and dividends. Does the MarketBeat Community prefer ENZ or OTRK? Enzo Biochem received 174 more outperform votes than Ontrak when rated by MarketBeat users. However, 59.38% of users gave Ontrak an outperform vote while only 53.00% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformEnzo BiochemOutperform Votes21253.00% Underperform Votes18847.00% OntrakOutperform Votes3859.38% Underperform Votes2640.63% Which has more risk and volatility, ENZ or OTRK? Enzo Biochem has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.93, indicating that its stock price is 193% more volatile than the S&P 500. Is ENZ or OTRK more profitable? Enzo Biochem has a net margin of -75.34% compared to Ontrak's net margin of -237.77%. Enzo Biochem's return on equity of -7.96% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Enzo Biochem-75.34% -7.96% -5.49% Ontrak -237.77%-171.34%-113.42% Do institutionals and insiders hold more shares of ENZ or OTRK? 36.9% of Enzo Biochem shares are owned by institutional investors. Comparatively, 12.9% of Ontrak shares are owned by institutional investors. 11.4% of Enzo Biochem shares are owned by insiders. Comparatively, 1.9% of Ontrak shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend ENZ or OTRK? Ontrak has a consensus target price of $45.00, suggesting a potential upside of 2,999.81%. Given Ontrak's stronger consensus rating and higher possible upside, analysts clearly believe Ontrak is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer ENZ or OTRK? In the previous week, Enzo Biochem and Enzo Biochem both had 2 articles in the media. Enzo Biochem's average media sentiment score of 0.00 equaled Ontrak'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enzo Biochem 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ontrak 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, ENZ or OTRK? Enzo Biochem has higher revenue and earnings than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnzo Biochem$29.09M0.53-$26.08MN/AN/AOntrak$11.24M0.54-$27.92M-$10.62-0.14 SummaryEnzo Biochem beats Ontrak on 8 of the 14 factors compared between the two stocks. Remove Ads Get Ontrak News Delivered to You Automatically Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OTRK vs. The Competition Export to ExcelMetricOntrakhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.12M$1.96B$5.24B$7.07BDividend YieldN/A7.11%4.87%4.05%P/E Ratio-0.1415.1421.1817.48Price / Sales0.543.95356.3585.27Price / CashN/A9.3238.1634.64Price / Book0.264.066.233.79Net Income-$27.92M$87.49M$3.20B$247.10M7 Day Performance-1.91%-2.82%-8.32%-7.32%1 Month Performance10.82%-5.41%-3.36%-10.19%1 Year Performance-75.18%-22.87%2.72%-7.41% Ontrak Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OTRKOntrak2.034 of 5 stars$1.45+3.3%$45.00+2,999.8%-78.6%$6.12M$11.24M-0.14250News CoverageENZEnzo Biochem0.5301 of 5 stars$0.49+0.8%N/A-75.0%$25.68M$29.09M0.00520Gap UpOPGNOpGenN/A$2.70flatN/A-34.4%$22.56M$2.67M0.00100Analyst ForecastCCMConcord Medical Services0.3683 of 5 stars$3.96+3.4%N/A-26.9%$17.19M$471.70M0.00970Analyst ForecastMRAIMarpaiN/A$1.15+21.1%$6.00+421.7%-59.8%$16.65M$34.87M-0.44150BRTXBioRestorative Therapies2.7925 of 5 stars$1.97+11.9%$18.00+813.7%+37.4%$13.63M$377,000.00-1.297Gap UpKDLYKindly MD0.6206 of 5 stars$2.18+44.4%N/AN/A$13.03M$2.88M0.00N/AEarnings ReportNews CoverageGap UpHigh Trading VolumeMGRXMangoceuticals0.2536 of 5 stars$4.75+6.5%N/A-95.8%$11.81M$755,000.00-0.823Upcoming EarningsSSYSunLink Health SystemsN/A$1.05-2.8%N/A+29.0%$7.39M$31.23M7.501,376Analyst ForecastNews CoverageNIVFNewGenIvf Group0.8718 of 5 stars$1.08+10.2%N/AN/A$5.69M$5.14M0.00N/ANews CoverageGap UpATIPATI Physical TherapyN/A$1.23+1.7%N/A-81.2%$5.43M$741.86M-0.075,600 Remove Ads Related Companies and Tools Related Companies ENZ Competitors OPGN Competitors CCM Competitors MRAI Competitors BRTX Competitors KDLY Competitors MGRX Competitors SSY Competitors NIVF Competitors ATIP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OTRK) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ontrak, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ontrak With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OTRK Stock Free OTRK Stock Alerts